Drimva

Legend Biotech

Patent Counsel/Senior Patent Counsel

$168K–$221K

Philadelphia, Pennsylvania, United States +3 · Senior · Full-time · Posted Sep 2, 2026

Location
Philadelphia, Pennsylvania, United States
Somerset, New Jersey, United States
Philadelphia, Pennsylvania, United States
Somerset, New Jersey, United States
Experience
8+ years of patent attorney experience.
Education
Undergraduate degree in biological sciences and U.S. law degree (J.D.); advanced degrees preferred.
Visa sponsorship
Applicants must be authorized to work in the United States; employment eligibility is verified through E-Verify.

About the job

Develops and manages global patent strategy and portfolios for biotechnology programs, advising on transactions, patent risks, and intellectual property agreements.

What you'll do

  • Drafts and prosecutes U.S. and foreign patent applications and manages global patent dockets and post-grant proceedings.
  • Conducts IP due diligence, freedom-to-operate, infringement, validity, and risk analyses for programs and strategic transactions.
  • Advises business and research stakeholders on IP strategy and negotiates intellectual property provisions in commercial and research agreements.

What they ask for

  • Undergraduate degree in biological sciences; U.S. law degree (J.D.).
  • Admission to practice before the USPTO and good-standing admission to at least one U.S. state bar.
  • 8+ years of life sciences patent attorney experience, primarily drafting and prosecuting patent applications in a pharma/biotech corporate setting and/or representing such clients in a law firm.
  • Experience building global biopharmaceutical IP portfolios and conducting complex freedom-to-operate analyses across technologies and jurisdictions.

Nice to have

  • Advanced degree.
  • Experience with strategic transaction support, adverse IP proceedings or litigation, and gene therapy, cell therapy, or RNA therapeutics.

Pay

$168,372 — $220,988 USD (base pay)

Tools

Microsoft Office, Word, Excel, PowerPoint, Outlook

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)